Cytiva equipment orders were reported as strong. Reported demand drivers include biologics, biosimilars, and advanced therapies. Manufacturing reshoring was also identified as supporting orders.
Key facts
Danaher's Cytiva equipment orders are described as strong, supported by biologics, biosimilars, advanced therapies, and manufacturing reshoring. source
Danaher identified growth in bioprocessing as central to its long-term outlook. source